However, Gal-3 can also exert autocrine effects in neuroblastoma cells by increasing phenotypic differentiation and by impairing MYCN-primed apoptosis via modulation of HIPK2 [22,23,24]. The gene discussed is LGALS3; the disease is neuroblastoma.